Skip to Main content Skip to Navigation
Master Thesis

Caractéristiques des patients atteints de gliome portant une mutation minoritaire de l'iso citrate déshydrogénase

Abstract : Approximately 10% of IDH-mutant gliomas harIndividual dynamic predictions using landmarking and joint modelling bour non-canonical IDH mutations (non-R132H IDH1 and IDH2 mutations). The aim of this study was to analyse the characteristics of non-canonical IDH-mutant gliomas. We retrospectively analysed the characteristics of 166 patients with non-canonical IDH mutant gliomas and compared them to those of 155 consecutive patients with IDH1 R132H mutant gliomas. The median age at diagnosis was 38 years in patients with non-canonical IDH mutant gliomas and 43 years in glioma patients with IDH1 R132H-mutant tumours. Family history of cancer was more frequent among glioma patients harbouring non-canonical IDH mutations than in patients with IDH1 R132H mutations (22.2% vs 5.1%; P<0.05). Tumours were predominantly localised in the frontal lobe regardless of the type of IDH mutation. Compared to IDH1 R132H-mutant gliomas, tumours with non-canonical IDH mutations were more frequently found in the infratentorial region (5.5% vs 0%; P<0,05) and were often multicentric (4.8% vs 0.9%; P<0.05). Compared to IDH1 R132H-mutant gliomas, tumours with non-canonical IDH1 mutations were more frequently astrocytomas (65.6% vs 43%, P<0.05), while those with IDH2 mutations were more frequently oligodendrogliomas (85% vs 48.3%; P<0.05). The median overall survival was similar in patients with IDH1 R132H-mutant gliomas and patients with non-canonical IDH-mutant gliomas. Gliomas with non-canonical IDH mutations have distinct radiological and histological characteristics. The presence of such tumours seems to be associated with genetic predisposition to cancer development and thus, patients diagnosed with gliomas with non-canonical IDH mutations should be discussed with oncogenetician.
Complete list of metadatas

Cited literature [70 references]  Display  Hide  Download

https://dumas.ccsd.cnrs.fr/dumas-02863691
Contributor : Médecine Ub <>
Submitted on : Wednesday, June 10, 2020 - 2:47:35 PM
Last modification on : Thursday, October 15, 2020 - 5:03:43 PM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : 2021-01-01

Please log in to resquest access to the document

Identifiers

  • HAL Id : dumas-02863691, version 1

Collections

Citation

Laura Poetsch-Beigt. Caractéristiques des patients atteints de gliome portant une mutation minoritaire de l'iso citrate déshydrogénase. Sciences du Vivant [q-bio]. 2020. ⟨dumas-02863691⟩

Share

Metrics

Record views

48